OPT
Price:
$3.63
Market Cap:
$583.35M
Opthea Limited, a clinical stage biopharmaceutical company, develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead asset is OPT 302, a soluble form of VEGFR 3 in clinical development as a novel therapy for wet neovascular age related macular degeneration and diabetic macular edema DME, as well as a first in class VEGF C/D inhibitors for treatment with VEGF A inhibitors for the trea...[Read more]
Industry
Biotechnology
IPO Date
2020-10-16
Stock Exchange
NASDAQ
Ticker
OPT
According to Opthea Limited’s latest financial reports and current stock price. The company's current PE Ratio is -1.32. This represents a change of 245.15% compared to the average of -0.38 of the last 4 quarters.
The mean historical PE Ratio of Opthea Limited over the last ten years is -10.28. The current -1.32 PE Ratio has changed 1.18% with respect to the historical average. Over the past ten years (40 quarters), OPT's PE Ratio was at its highest in in the June 2008 quarter at 0. The PE Ratio was at its lowest in in the December 2019 quarter at -24.67.
Average
-10.28
Median
-6.41
Minimum
-38.14
Maximum
-0.67
Discovering the peaks and valleys of Opthea Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 411.37%
Maximum Annual PE Ratio = -0.67
Minimum Annual Increase = -85.27%
Minimum Annual PE Ratio = -38.14
Year | PE Ratio | Change |
---|---|---|
2024 | -0.67 | -17.83% |
2023 | -0.81 | -63.33% |
2022 | -2.21 | -60.63% |
2021 | -5.62 | -85.27% |
2020 | -38.14 | 411.37% |
2019 | -7.46 | 3.44% |
2018 | -7.21 | -67.93% |
2017 | -22.49 | 72.70% |
2016 | -13.02 | 150.42% |
2015 | -5.20 | 97.14% |
The current PE Ratio of Opthea Limited (OPT) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.23
5-year avg
-9.49
10-year avg
-10.28
Opthea Limited’s PE Ratio is greater than Molecular Partners AG (-2.46), less than MediciNova, Inc. (-0.04), greater than Anebulo Pharmaceuticals, Inc. (-5.30), greater than Champions Oncology, Inc. (-178.90), greater than Cyteir Therapeutics, Inc. (-9.12), less than Aerovate Therapeutics, Inc. (-0.89), greater than Adagene Inc. (-2.67), greater than Acrivon Therapeutics, Inc. Common Stock (-3.08), greater than Rezolute, Inc. (-4.44), less than AN2 Therapeutics, Inc. (-0.67), less than Inhibrx Biosciences, Inc. (0.14), greater than Mineralys Therapeutics, Inc. (-4.16), less than Eliem Therapeutics, Inc. (0),
Company | PE Ratio | Market cap |
---|---|---|
-2.46 | $195.74M | |
-0.04 | $101.53M | |
-5.30 | $42.01M | |
-178.90 | $108.76M | |
-9.12 | $108.71M | |
-0.89 | $75.07M | |
-2.67 | $85.89M | |
-3.08 | $193.98M | |
-4.44 | $255.53M | |
-0.67 | $40.64M | |
0.14 | $209.76M | |
-4.16 | $637.04M | |
0 | $342.68M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Opthea Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Opthea Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Opthea Limited's PE Ratio?
How is the PE Ratio calculated for Opthea Limited (OPT)?
What is the highest PE Ratio for Opthea Limited (OPT)?
What is the 3-year average PE Ratio for Opthea Limited (OPT)?
What is the 5-year average PE Ratio for Opthea Limited (OPT)?
How does the current PE Ratio for Opthea Limited (OPT) compare to its historical average?